DEA investigators flagged years of suspicious prescription patterns at a longtime pharmacy in Cumming — but never talked to a single employee before moving to suspend its license.
Inside the DEA's case against Goodson Drug — and the pharmacy's rebuttal to accusations of fueling opioid abuse
Part 2 of 3 in FCN investigative report